Loading...
Loading...
BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust. Spoken Alpha tracks BMEZ's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BMEZ's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BMEZ.
curl https://api.spokenalpha.com/v1/companies/BMEZ| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.49 | $1.63 | -8.3% | -2.8% | -4.8% |
| Q4 FY2026 | $1.45 | $1.69 | -14.3% | +3.0% | +1.1% |
| Q3 FY2026 | $1.46 | $1.79 | -18.6% | -0.2% | -0.5% |
| Q2 FY2026 | $1.47 | $1.80 | -18.2% | -2.0% | +0.4% |
| Q1 FY2025 | $1.53 | $1.83 | -16.4% | +5.0% | +4.4% |
| Q4 FY2025 | $1.57 | $1.86 | -15.4% | -3.4% | -3.6% |
| Q3 FY2025 | $1.60 | $1.80 | -11.1% | +5.0% | +5.4% |
| Q2 FY2025 | $1.60 | $2.00 | -20.0% | -1.6% | -4.2% |
| Q1 FY2024 | $1.66 | $1.83 | -9.4% | +2.8% | +1.4% |
| Q4 FY2024 | $1.81 | $1.99 | -9.0% | +3.8% | +5.9% |